Evaluating magnetoencephalography for pediatric brain tumors
Non-Helium Magnetoencephalography for Clinical Management of Pediatric Brain Tumors : An Observational Cohort Study
This study is testing if a special brain imaging technique called magnetoencephalography can help doctors find brain tumors in kids more accurately than regular scans like CT and MRI.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 3 Years to 18 Years |
| Sex | All |
| Sponsor | Guangzhou Women and Children's Medical Center Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06943742 on ClinicalTrials.gov |
What this trial studies
This observational study assesses the effectiveness of magnetoencephalography (MEG) in the preoperative evaluation of pediatric brain tumors. It aims to compare the localization accuracy of MEG with traditional imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI). Participants aged 3 to 18 years will undergo both MEG and CT/MRI examinations, with follow-up assessments at 1, 3, and 6 months post-surgery to evaluate the extent of tumor resection and overall quality of life. The study seeks to determine the clinical efficacy of MEG in guiding surgical decisions.
Who should consider this trial
Good fit: Ideal candidates are children aged 3 to 18 years who have been clinically diagnosed with a brain tumor and can cooperate with MEG evaluations.
Not a fit: Patients with serious comorbidities, neurological or psychiatric disorders, or those unsuitable for surgical procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the precision of preoperative assessments for pediatric brain tumors, potentially leading to better surgical outcomes.
How similar studies have performed: While the use of MEG in brain tumor assessment is promising, this specific approach has not been extensively tested in pediatric populations, making it a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age range: 3-18 years old; * Clinically diagnosed with brain tumor; * Capable of cooperating with magnetoencephalography evaluation and recording. Exclusion Criteria: * Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination. * Patients using drugs that affect central nervous system function; * Patients who are not suitable for surgical procedures; * Patients with progressive neurological disorders.
Where this trial is running
Guangzhou, Guangdong
- Guangzhou Women and Children's medical center — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Ye Song, Medical Doctor
- Email: 15625984282@163.com
- Phone: +86-020-81886332
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.